Intervention group 1: Teriparatide 20 mcg daily subcutaneously for one year.

2 trials

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

Conditions

Osteoporosis. Idiopathic osteoporosisSecondary osteoporosis. Osteoporosis with pathological fracture

Phase 2

Effect of Teriparatide, Alendronate, and Zoledronic Acid on treatment of secondary osteoporosis

Active, not recruitingIRCT201605159014N98

Vice-chancellor for Research the Technology, Hamadan University of Medical SciencesSecondary osteoporosis. Osteoporosis with pathological fracture

Start: 2016-05-04Target: 120Updated: 2018-02-22

Effect of Teriparatide, Alendronate, Zoledronic Acid, and combined effect of Teriparatide and Alendronate treatment of primary osteoporosis

Active, not recruitingIRCT201605169014N99

Vice-chancellor for Research the Technology, Hamadan University of Medical SciencesOsteoporosis. Idiopathic osteoporosis

Start: 2006-06-05Target: 120Updated: 2018-02-22